Clinical Trials Logo

Retinopathy clinical trials

View clinical trials related to Retinopathy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04008121 Not yet recruiting - Clinical trials for Diabetic Retinopathy

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium

Start date: April 2024
Phase: Early Phase 1
Study type: Interventional

The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and diseased eyes using fluorescent angiography for retinal vascular disease diagnosis and monitoring.

NCT ID: NCT00331370 Not yet recruiting - Hypertension Clinical Trials

Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility

Start date: May 2006
Phase: N/A
Study type: Interventional

Damage to very small blood vessels is a consequence, but can also precede high blood pressure. Such damage, measured by disturbances in the vessels in the retina (back of the eye) is a strong predictor of heart disease and stroke. South Asian people have one of the highest rates of hypertension in the world (30% in adults). In Pakistan, this is usually severe, undetected and untreated. The Wellcome Trust has already funded a study of blood pressure control in adults and children in this population. We propose a substudy, taking photographs of the retina and making measurements of the vessels, to determine whether such blood pressure related changes occur at an early age in young children with a family history of high blood pressure compared to those without, whether such changes predict an increase in blood pressure over time, and whether, in adults, such changes can be reversed by blood pressure treatment. The hypothesis of our study is: young offspring of South Asian people with hypertension have a disturbed microcirculation, as assessed by abnormalities of retinal vessels, compared to offspring of normotensive parents. Our 2nd hypothesis is: Abnormal retinal vascular geometry will improve proportionately to achieved reductions in BP.